Citations

Showing 10 of 108094 citations.

P18 Pemigatinib for previously treated locally advanced or metastatic cholangiocarcinoma: final results from FIGHT-202
Sahai, Vaibhav , Vaccaro, Gina M. , Rajabi, Raed MAl, Paulson, Andrew Scott , Gallinson, David, Oh, Do‐Youn , Catenacci, Daniel V.T. , Lihou, Christine , Véronèse, L., Sahai, Vaibhav , Vogel, Arndt , Hollebecque, Antoine , Melisi, Davide , Borad, Mitesh J. , Murphy, Adrian , Dotan, Efrat , Cutsem, Eric Van , Zhen, Huiling, Abou‐Alfa, Ghassan K.

Mayo Clinic

Abstracts | September 20, 2022 | Volume: No volume available | Issue: No issue available | Pages: A44.1-A44

10.1136/gutjnl-2022-basl.69 Get It

P09 Long-term obeticholic acid (OCA) for Primary Biliary Cholangitis (PBC) in a clinical trial improved event free survival (death, liver transplant and hepatic decompensation) compared to external controls from the GLOBAL PBC real-world database
Perez, Carla , Adekunle, Femi, Mayne, Tracy J. , Malecha, Elizabeth Smoot, Ness, Eric , Meer, Adriaan J Van Der, Nevens, Frederik , Bruns, Tony , Floreani, Annarosa , Mayo, Marlyn J. , Thorburn, Douglas , Gulamhusein, Aliya , Bowlus, Christopher L. , Lindor, Keith D. , Bruns, Tony , Bowlus, Christopher L , Meer, Adriaan van der , Lammers, Willem J. , Trivedi, Palak Jitendrakumar , Battezzati, Pier Maria , Kowdley, Kris V. , Cazzagon, Nora , Mason, Andrew L. , Parés, Albert , Londoño, Maria, Invernizzi, Pietro , Carbone, Marco , Lleò, Ana , Dalekos, George Ν. , Gatselis, Nikolaos , Verhelst, Xavier , Janssen, Harry L.A. , Trauner, Michael , Corpechot, Christophe , Hirschfield, Gideon M. , Hansen, Bettina E.

Mayo Clinic

Abstracts | September 20, 2022 | Volume: No volume available | Issue: No issue available | Pages: A37-A37

10.1136/gutjnl-2022-basl.60 Get It

Role of Inferior Vena Cava Dynamics for Estimating Right Atrial Pressure in Congenital Heart Disease
Egbe, Alexander C. , Connolly, Heidi M. , Pellikka, Patricia A. , Anderson, Jason H. , Miranda, William R. , Pellikka, Patricia A , Anderson, Jason

Mayo Clinic

Circulation: Cardiovascular Imaging | September 20, 2022 | Volume: 15 | Issue: 9 | Pages: No page available

10.1161/circimaging.122.014308 | PMID 36126125 Get It

Background: Inferior vena cava (IVC) size and collapsibility (IVC dynamics) are used for estimating right atrial pressure (RAP). However, the diagnostic performance of the American Society of Echocardiography IVC criteria for estimating RAP in patients with congenital heart disease are unknown. The purpose of this study was to assess the role of IVC dynamics for estimating RAP in adults with congenital heart disease. Methods: We conducted a retrospective study of adults with congenital heart disease that underwent cardiac catheterization and echocardiogram at Mayo Clinic (2003–2019). IVC diameter was measured at inspiration (IVC min ) and end-expiration (IVC max ), and IVC collapsibility index (IVC CI ) was calculated. Results: Based on 918 patients, we observed a good correlation between IVC max and invasive RAP ( r =0.56, P <0.001); IVC min and RAP ( r =0.58, P <0.001); and IVC CI ( r =−0.72, P <0.001). There was excellent correlation between invasive RAP and estimated RAP using IVC CI ( r =0.80, P <0.001). We observed that IVC CI <60% had superior diagnostic performance as compared with American Society of Echocardiography criteria (IVC max >2.1 cm, area under the curve difference 0.15, P <0.001; IVC CI <50%, area under the curve difference 0.09, P =0.008; combination of IVC max >2.1 cm; and IVC CI <50%, area under the curve difference 0.06, P =0.02). Estimated RAP >10 mm Hg based on IVC CI had comparable prognostic performance as invasive RAP but superior prognostic performance as the American Society of Echocardiography criteria. Conclusions: IVC CI <60% was the best criterion to identify patients with elevated RAP. IVC CI was comparable to invasively measured RAP in its relation to prognosis. Further studies are required to determine whether the use of IVC CI in clinical decision-making will improve clinical outcomes in this population.
Post-Transplant and In-Hospital Risk Factors for ARDS After Hematopoietic Stem Cell Transplantation
Frank, Ryan D. , Yadav, Hemang , Herasevich, Svetlana , Hogan, William J. , Alkhateeb, Hassan B. , Limper, Andrew H. , Gajic, Ognjen

Mayo Clinic

Respiratory Care | September 20, 2022 | Volume: 68 | Issue: 1 | Pages: 77-86

10.4187/respcare.10224 | PMID 36127128 Get It

BACKGROUND: ARDS is a serious complication of hematopoietic stem cell transplant (HSCT). Pre-transplant risk factors for developing ARDS after HSCT have been recently identified. The objective of this study was to better understand post-transplant risk factors for developing ARDS after HSCT. METHODS: This was a nested case-control study. ARDS cases were matched to hospitalized non-ARDS controls by age, type of transplantation (allogeneic vs autologous), and time from transplantation. In a conditional logistic regression model, any potential risk factors were adjusted a priori for risk factors known to be associated with ARDS development. RESULTS: One hundred and seventy ARDS cases were matched 1:1 to non-ARDS hospitalized controls. Pre-admission, cases were more likely to be on steroids (odds ratio [OR] 1.90 [1.13–3.19], P = .02). At time of admission, cases had lower platelet count (OR 0.95 [0.91–0.99], P = .02), lower bicarbonate (OR 0.94 [0.88–0.99], P = .035), and higher creatinine (OR 1.91 [1.23–2.94], P = .004). During the first 24 h after admission, cases were more likely to have received transfusion (OR 2.41 [1.48–3.94], P < .001), opioids (OR 2.94 [1.67–5.18], P < .001), and have greater fluid administration (OR 1.52 [1.30–1.78], P < .001). During the hospitalization, ARDS cases had higher temperature (OR 1.77 [1.34–2.33], P < .001) and higher breathing frequency (OR 1.52 [1.33–1.74], P < .001). ARDS cases were more likely to have had sepsis (OR 68.0 [15.2–301.7], P < .001), bloodstream infection (OR 4.59 [2.46–8.57], P < .001), and pneumonia (OR 9.76 [5.01–19.00], P < .001). CONCLUSIONS: Several post-transplant predictors of ARDS development specific to the HSCT population were identified in the pre-hospital and early in-hospital domains. These findings can provide insights into causal mechanisms of ARDS development and be used to develop HSCT-specific risk prediction models.
Differentiation of hydrochlorothiazide-induced dermatitis from stasis dermatitis
Abdelwahab, Rewan , Tangalos, Eric G., Matulis, John C. , Matulis, John

Mayo Clinic

BMJ Case Reports | September 20, 2022 | Volume: 15 | Issue: 9 | Pages: e249884

10.1136/bcr-2022-249884 | PMID 36127034 Get It

A woman in her 60s with a history of hypertension and stasis dermatitis presented to a primary care clinic with a bilateral, erythematous rash on the legs, stomach, and chest. Photosensitive rash and dermatitis may be caused by many conditions. Hydrochlorothiazide-induced dermatitis is a rare side effect of thiazide diuretics. Early identification of sulfa-sensitivity and photoallergic or phototoxic reaction is essential to accurate diagnosis and treatment of photosensitive dermatitis. Soliciting a targeted history is essential to delineating drug-induced dermatitis from stasis dermatitis. A thorough skin examination can elucidate the focal or extensive nature of the rash and is essential to making an accurate diagnosis. Immediate cessation of hydrochlorothiazide and switching drugs classes for hypertension management typically leads to resolution of symptoms.
Assessment of Disparities in Diabetes Mortality in Adults in US Rural vs Nonrural Counties, 1999-2018
Dugani, Sagar B. , Wood‐Wentz, Christina M. , Bailey, Kent R., Dugani, Sagar B , Mielke, Michelle M. , Vella, Adrian

Mayo Clinic

JAMA Network Open | September 20, 2022 | Volume: 5 | Issue: 9 | Pages: e2232318

10.1001/jamanetworkopen.2022.32318 | PMID 36125809 Get It

Importance US rural vs nonrural populations have striking disparities in diabetes care. Whether rurality contributes to disparities in diabetes mortality is unknown. Objective To examine rates and trends in diabetes mortality based on county urbanization. Design, Setting, and Participants In this observational, cross-sectional study, the US Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research database was searched from January 1, 1999, to December 31, 2018, for diabetes as a multiple cause and the underlying cause of death among residents aged 25 years or older in US counties. County urbanization was categorized as metro, medium-small, and rural. Weighted multiple linear regression models and jackknife resampling, with a 3-segment time component, were used. The models included exposures with up to 3-way interactions and were age standardized to the 2009-2010 population. The analyses were conducted from July 1, 2020, to February 1, 2022. Exposures County urbanization (metro, medium-small, or rural), gender (men or women), age group (25-54, 55-74, or ≥75 years), and region (Midwest, Northeast, South, or West). Main Outcomes and Measures Annual diabetes mortality rate per 100 000 people. Results From 1999-2018, based on 4 022 238 309 person-years, diabetes was a multiple cause of death for 4 735 849 adults aged 25 years or older. As a multiple cause, diabetes mortality rates in 2017-2018 vs 1999-2000 were highest and unchanged in rural counties (157.2 [95% CI, 150.7-163.7] vs 154.1 [95% CI, 148.2-160.1]; P = .49) but lower in medium-small counties (123.6 [95% CI, 119.6-127.6] vs 133.6 [95% CI, 128.4-138.8]; P = .003) and urban counties (92.9 [95% CI, 90.5-95.3] vs 109.7 [95% CI, 105.2-114.1]; P &lt; .001). In 2017-2018 vs 1999-2000, mortality rates were higher in rural men (+18.2; 95% CI, 14.3-22.1) but lower in rural women (−14.0; 95% CI, −17.7 to −10.3) ( P &lt; .001 for both). In the 25- to 54-year age group, mortality rates in 2017-2018 vs 1999-2000 showed a greater increase in rural counties (+9.4; 95% CI, 8.6-10.2) compared with medium-small counties (+4.5; 95% CI, 4.0-5.0) and metro counties (+0.9; 95% CI, 0.4-1.4) ( P &lt; .001 for all). Of all regions and urbanization levels, the mortality rate in 2017-2018 vs 1999-2000 was higher only in the rural South (+13.8; 95% CI, 7.6-20.0; P &lt; .001). Conclusions and Relevance In this cross-sectional study, US rural counties had the highest overall diabetes mortality rate. The determinants of persistent rural disparities, in particular for rural men and for adults in the rural South, require investigation.
Computer clinical decision support that automates personalized clinical care: a challenging but needed healthcare delivery strategy
Morris, Alan H. , Horvat, Christopher M. , Grainger, David W. , Orme, James F., Clemmer, Terry P., Weaver, Lindell K., Thomas, Frank O, Grissom, Colin K. , Hirshberg, Ellie , East, Thomas D. , Wallace, C. Jane, Young, Michael , Sittig, Dean F. , Pearl, James E., Pesenti, Antinio, Bombino, Michela, Beck, Eduardo, Sward, Katherine , Phansalkar, Shobha, Bernard, Gordon R. , Brower, Roy G., Truwit, Jonathon D. , Steingrub, Jay S. , Hiten, R Duncan, Willson, Douglas F., Randolph, Adrienne G. , Curley, Martha A. Q. , Newth, Christopher J. L. , Lacroix, Jacques, Agus, Michael S. D. , Lee, Kang Hoe, deBoisblanc, Bennett P., Moore, Frederick A. , Evans, R. Scott, Sorenson, Dean, Wong, Anthony, Boland, Michael V. , Dere, W. , Crandall, Alan S. , Huff, Stanley M. , Haug, Peter J. , Pielmeier, Ulrike , Rees, Stephen Edward , Karbing, Dan Stieper , Berger, Kenneth I. , Oppenheimer, Beno W. , Pickering, Brian W. , Schoenfeld, David , Tocino, Irena , Savitz, Lucy A., Dreyfuss, Didier, Slutsky, Arthur S. , Crapo, James D. , Pinsky, Michael R. , James, Brent C., Berwick, Donald M. , Sittig, Dean F , Sward, Katherine A , Weir, Charlene , Huff, Stanley M , Gonnering, Russell S , Randolph, Adrienne G , Stagg, Brian C. , Lanspa, Michael J. , Suchyta, Mary R. , Thompson, Bruce , Zimmerman, Jerry J. , Nadkarni, Vinay , Facelli, Julio Cesar , Andreassen, Steen , Fan, Eddy , Goldring, Roberta M. , Ely, Eugene Wesley , Pronovost, Peter J.

Mayo Clinic

Journal of the American Medical Informatics Association | September 20, 2022 | Volume: 30 | Issue: 1 | Pages: 178-194

10.1093/jamia/ocac143 | PMID 36125018 Get It

AbstractHow to deliver best care in various clinical settings remains a vexing problem. All pertinent healthcare-related questions have not, cannot, and will not be addressable with costly time- and resource-consuming controlled clinical trials. At present, evidence-based guidelines can address only a small fraction of the types of care that clinicians deliver. Furthermore, underserved areas rarely can access state-of-the-art evidence-based guidelines in real-time, and often lack the wherewithal to implement advanced guidelines. Care providers in such settings frequently do not have sufficient training to undertake advanced guideline implementation. Nevertheless, in advanced modern healthcare delivery environments, use of eActions (validated clinical decision support systems) could help overcome the cognitive limitations of overburdened clinicians. Widespread use of eActions will require surmounting current healthcare technical and cultural barriers and installing clinical evidence/data curation systems. The authors expect that increased numbers of evidence-based guidelines will result from future comparative effectiveness clinical research carried out during routine healthcare delivery within learning healthcare systems.
Accommodating Bereaved Parents in the Workplace: A Scoping Review
Schoonover, Kimberly , Yadav, Hemang , Schoonover, Kimberly L, Prokop, Larry J. , Lapid, Maria I.

Mayo Clinic

Journal of Loss and Trauma | September 20, 2022 | Volume: 28 | Issue: 4 | Pages: 348-363

10.1080/15325024.2022.2122221 | PMID 37635848 Get It

Promoting validation and cross-phylogenetic integration in model organism research
Cheng, Keith C. , Burdine, Rebecca D. , Dickinson, Mary E. , Lloyd, K. C. Kent , MacRae, Calum A. , Morrison, John H., O’Connor, David H. , Rogers, Crystal D. , Sánchez, Susan , Simpson, J. , Talbot, William S. , Wallace, Douglas C. , Bellen, Hugo J , O'Connor, David H , Ekker, Stephen C. , Lin, Alex Y. , Lutz, Cathleen M. , Postlethwait, John H. , Weimer, Jill M. , Bellen, Hugo J.

Mayo Clinic

Disease Models & Mechanisms | September 20, 2022 | Volume: 15 | Issue: 9 | Pages: No page available

10.1242/dmm.049600 | PMID 36125045 Get It

ABSTRACT Model organism (MO) research provides a basic understanding of biology and disease due to the evolutionary conservation of the molecular and cellular language of life. MOs have been used to identify and understand the function of orthologous genes, proteins, cells and tissues involved in biological processes, to develop and evaluate techniques and methods, and to perform whole-organism-based chemical screens to test drug efficacy and toxicity. However, a growing richness of datasets and the rising power of computation raise an important question: How do we maximize the value of MOs? In-depth discussions in over 50 virtual presentations organized by the National Institutes of Health across more than 10 weeks yielded important suggestions for improving the rigor, validation, reproducibility and translatability of MO research. The effort clarified challenges and opportunities for developing and integrating tools and resources. Maintenance of critical existing infrastructure and the implementation of suggested improvements will play important roles in maintaining productivity and facilitating the validation of animal models of human biology and disease.
Single-Cell Infection of Influenza A Virus Using Drop-Based Microfluidics
Loveday, Emma K. , Sanchez, Humberto S. , Thomas, Mallory M. , Chang, Connie B. , Loveday, Emma Kate , Chang, Connie B

Mayo Clinic

Microbiology Spectrum | September 20, 2022 | Volume: 10 | Issue: 5 | Pages: No page available

10.1128/spectrum.00993-22 | PMID 36125315 Get It

Drop-based microfluidics is a cutting-edge tool in single-cell research. Here, we used drop-based microfluidics to encapsulate thousands of individual cells infected with influenza A virus within picoliter-sized drops.